MedPath

PHOENIX CHILDREN'S HOSPITAL

🇺🇸United States
Ownership
-
Established
1983-01-01
Employees
-
Market Cap
-
Website
http://www.phoenixchildrens.org/

Clinical Trials

38

Active:1
Completed:17

Trial Phases

5 Phases

Early Phase 1:1
Phase 2:2
Phase 3:1
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (28 trials with phase data)• Click on a phase to view related trials

Not Applicable
15 (53.6%)
Phase 4
9 (32.1%)
Phase 2
2 (7.1%)
Early Phase 1
1 (3.6%)
Phase 3
1 (3.6%)

Ovarian Tissue Cryopreservation

Not Applicable
Recruiting
Conditions
Infertility, Female
First Posted Date
2024-11-28
Last Posted Date
2024-11-28
Lead Sponsor
Phoenix Children's Hospital
Target Recruit Count
40
Registration Number
NCT06710769
Locations
🇺🇸

Phoenix Childrens, Phoenix, Arizona, United States

Benefits of Intrahospital Exercise Program in Pediatric HSCT

Not Applicable
Completed
Conditions
Hematopoietic Stem Cell Transplant
Pediatric Cancer
Deconditioning
First Posted Date
2024-11-18
Last Posted Date
2024-11-18
Lead Sponsor
Phoenix Children's Hospital
Target Recruit Count
40
Registration Number
NCT06692478
Locations
🇺🇸

Phoenix Children's Hospital, Phoenix, Arizona, United States

A Clinical Trial of Soluble Fiber for Asthma

Phase 2
Not yet recruiting
Conditions
Asthma in Children
Interventions
First Posted Date
2024-04-17
Last Posted Date
2025-05-31
Lead Sponsor
Phoenix Children's Hospital
Target Recruit Count
105
Registration Number
NCT06372249
Locations
🇺🇸

Phoenix Children's, Phoenix, Arizona, United States

Point of Care Lung Ultrasound in Preterm Infants with Respiratory Distress

Conditions
Bronchopulmonary Dysplasia
First Posted Date
2023-06-29
Last Posted Date
2024-11-28
Lead Sponsor
Phoenix Children's Hospital
Target Recruit Count
150
Registration Number
NCT05925075
Locations
🇺🇸

Phoenix Children's, Phoenix, Arizona, United States

Oral Penicillin Challenge and Allergy De-labeling in Children

Phase 4
Terminated
Conditions
Penicillin Allergy
Interventions
First Posted Date
2022-10-03
Last Posted Date
2024-06-14
Lead Sponsor
Phoenix Children's Hospital
Target Recruit Count
31
Registration Number
NCT05563610
Locations
🇺🇸

Phoenix Children's, Phoenix, Arizona, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

News

Anuncia Medical's ReFlow EVD Receives FDA Breakthrough Device Designation for Intracranial Pressure Management

Anuncia Medical has received FDA Breakthrough Device Designation for its ReFlow EVD, designed to manage brain swelling and elevated intracranial pressure through a novel noninvasive flushing mechanism.

© Copyright 2025. All Rights Reserved by MedPath